Clinical Drug Experience Knowledgebase

carboplatin (paraplatin) (5 trials)

cisplatin (platinol) (5 trials)

etoposide (vepesid) (8 trials)

ifosfamide (ifex) (6 trials)

autologous hematopoietic cell (3 trials)

busulfan (myleran) (1 trial)

cyclophosphamide (cytoxan) (4 trials)

dacarbazine (dtic-dome) (3 trials)

dactinomycin (cosmegen) (2 trials)

dexamethasone (1 trial)

doxorubicin (Doxil) (6 trials)

idarubicin (idamycin) (1 trial)

imatinib (gleevec) (1 trial)

inotuzumab ozogamicin (besponsa) (1 trial)

iobenguane sulfate i-131 (2 trials)

isotretinoin (accutane) (2 trials)

lomustine (1 trial)

melphalan (alkeran) (4 trials)

naltrexone (revia) (1 trial)

peripheral blood hematopoietic cell (2 trials)

prednisone (meticorten) (1 trial)

sargramostim (leukine) (3 trials)

topotecan (hycamtin) (2 trials)

trophosphamide (1 trial)

vincristine (oncovin) (7 trials)

autologous bone marrow (1 trial)

tretinoin (Retin-A) (1 trial)